美国辉瑞制药公司将对124批次婴童布洛芬产品(Advil)进行召回。

    据报道，此次召回主要是因为如果在服用该药物前不按说明摇匀，每次所服用的布洛芬剂量可能不均。

    加拿大卫生部表示，此次召回的药物包括Advil小儿滴剂(Advil Pediatric Drops)、儿童感冒Advil(Children's Advil Cold)等五种Advil产品。

    作为预防措施，加拿大卫生部建议消费者立即停止使用这些产品，并将其退回到药房。

内容来源：环球时报-环球网

以下为加拿大卫生部官网原文：

Pfizer Consumer Healthcare recalling 126 lots of Advil liquid products for infants and children

Health Canada is informing Canadians that Pfizer Consumer Healthcare has initiated a voluntary recall of 126 lots of Advil liquid products for infants and children because of a potential risk of inconsistences in dosing of the product.

“Clumps” of Ibuprofen may form in the bottle and lead to higher or lower doses that are given to infants and children if it is not shaken well before each use.

Lower doses may not be adequate in reducing the fever, leading to other health issues which could include, in rare instances, convulsions. Although unlikely, higher doses may lead to vomiting, drowsiness, dizziness, ‘ringing in the ears’ and decreased breathing rates.

The likelihood of these potentially severe adverse consequences is remote as long as the product has always been shaken well before each use as per label instructions.

As a precaution, Health Canada is recommending that consumers stop using these products and return them to a pharmacy.

Health Canada is advising parents who have given these products to their children and have concerns to consult with their health care practitioner.

Health Canada is monitoring Pfizer’s recall and will inform Canadians if new safety information arises.

2万家药店招聘，6万名药师求职，上康强医疗人才网 www.kq36.com